# Granules India Ltd-$ (GRANULES)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹766.35
Day Change: -2.98%
52W High: ₹761.4
52W Low: ₹432.6
Market Cap: ₹18,041 Cr

## Valuation
P/E: 29.79
P/B: 3.51
EPS: ₹24.44
Book Value: ₹207.61
Dividend Yield: 0.24%

## Returns
1Y Return: 41.02%

## Profitability
ROE: 13.52%
ROCE: 15.55%
Debt/Equity: 0.3
Revenue Growth: 22.8%
Profit Growth: 31.3%
EBITDA Margin: 22.09%
Operating Margin: 18.38%

## About
Granules India Ltd-$ is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Granules India Ltd-$ makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Concall Transcript: Transcript Of The Earnings Conference Call For Q4 And Financial Year Ended On March 31, 2026.
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-06-08T20:00:07.519Z
Price History Updated: 2026-06-08T18:00:32.487Z
Latest Price History Date: 2026-06-08
Technicals Updated: 2026-06-08T18:00:32.487Z
Quant Updated: 2026-06-08T18:00:32.487Z
Sentiment Updated: 2026-06-08T18:00:32.487Z
Financials Status: current
Financials Updated: 2026-05-18T09:31:04.948Z
Financials Last Attempt: 2026-05-18T09:31:04.948Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (Mar 2016)
Revenue: ₹1292 Cr
Operating Profit: ₹210 Cr (OPM 16%)
Net Profit: ₹91 Cr
Tax: ₹128 Cr

## Annual P&L History
Mar 2016: Rev ₹1292Cr | PAT ₹91Cr | OPM 16%
Mar 2017: Rev ₹1357Cr | PAT ₹123Cr | OPM 20%
Mar 2018: Rev ₹1411Cr | PAT ₹165Cr | OPM 21%

## Balance Sheet (Mar 2016)
Total Assets: ₹1203 Cr
Total Liabilities: ₹1203 Cr
Borrowings: ₹482 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Krishna Prasad Chigurupati B.Sc., Chairman & MD
- Priyanka  Chigurupati, Head of Marketing & Executive Director
- Harsha  Chigurupati BBA, Executive Director
- Ramraj  Rangarajalu, President & Head of Formulations Operations
- P. N. Baskaran, President - Head API Manufacturing & Operations

---
Source: rupiya.io/stocks/granules
Disclaimer: For research and education only. Not investment advice.